Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Emmett, Maxine S ^a   Symonds, Kirsty E ^a   Rigby, Howard ^b   Cook, Martin G ^c   Price, Rebecca ^b   Metcalfe, Chris ^a   Orlando, Antonio ^b   Bates, David O ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ANALYTIC METHOD; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH VESSEL; MELANOMA; METASTASIS; METASTASIS POTENTIAL; NON INVASIVE MEASUREMENT; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SHIELDS INDEX; AGED; CANCER STAGING; COMPARATIVE STUDY; EVALUATION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; REGISTER; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TIME;

ADULT; AGED; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TIME FACTORS;

EID: 77952224268     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-208     Document Type: Article

References (22)

1. White RR, Stanley WE, Johnson JL, Tyler DS, Seigler HF. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg 2002, 235(6):879-887. 10.1097/00000658-200206000-00017, 1422519, 12035046.
2. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355(13):1307-1317. 10.1056/NEJMoa060992, 17005948.
3. Cuchet E, Pinel N, Corcella D, Vuillez JP, Lebeau J, Moutet F, Colonna M, Leccia MT. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up. Eur J Dermatol 2007, 17(5):387-391.
4. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005, 242(3):302-311. discussion 311-303., 1357739, 16135917.
5. Caraco C, Marone U, Celentano E, Botti G, Mozzillo N. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol 2007, 14(9):2662-2667. 10.1245/s10434-007-9433-5, 17597345.
6. Zitelli JA. Sentinel lymph node biopsy: an alternate view. Dermatol Surg 2008, 34(4):544-549. discussion 549., 10.1111/j.1524-4725.2007.34099.x, 18261108.
7. Thompson JF. The value of sentinel node biopsy in patients with primary cutaneous melanoma. Dermatol Surg 2008, 34(4):550-554. 10.1111/j.1524-4725.2007.34100.x, 18261107.
8. Shields JD, Borsetti M, Orlando A, Rigby H, Jackson D, Mortimer PS, Levick JR, Bates DO. An index to predict prognosis of malignant melanoma using lymphatic vessel density and invasion. J Vasc Res 2003, 40:303.
9. Shields JD, Borsetti M, Rigby H, Harper SJ, Mortimer PS, Levick JR, Orlando A, Bates DO. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 2004, 90(3):693-700. 10.1038/sj.bjc.6601571, 2409610, 14760386.
10. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm MC, Detmar M. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003, 162(6):1951-1960. 1868148, 12759251.
11. Shields JD, Borsetti M, Orlando A, Rigby H, Mortimer PS, Levick JR, Bates DO. Lack of active lymphangiogenesis in malignant melanoma despite increased lymphatic density and lymphangiogenic growth factor expression. J Physiology 2003, 555P:PC37.
12. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005, 97(16):1180-1184.
13. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
14. Joory KD, Shields JD, Levick JR, Mortimer PS, Bates DO. PC18 Peritumour lymphatic density (LD) in metastatic malignant melanoma lies within the range of superficial dermal LD in normal human skin. Microcirculation 2004, 11(6):544-545.
15. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999, 144(4):789-801. 10.1083/jcb.144.4.789, 2132933, 10037799.
16. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7(2):192-198. 10.1038/84643, 11175850.
17. Shields JD, Emmett MS, Dunn DB, Joory KD, Sage LM, Rigby H, Mortimer PS, Orlando A, Levick JR, Bates DO. Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis. Oncogene 2007, 26(21):2997-3005. 10.1038/sj.onc.1210114, 17130836.
18. Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling. Cancer Cell 2007, 11(6):526-538. 10.1016/j.ccr.2007.04.020, 17560334.
19. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007, 109(3):1010-1017. 10.1182/blood-2006-05-021758, 1785149, 17032920.
20. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007, 170(2):774-786. 10.2353/ajpath.2007.060761, 1851877, 17255343.
21. Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001, 93(21):1638-1643.
22. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004, 10(7):2351-2358. 10.1158/1078-0432.CCR-03-0195, 15073111.